Strumento inattivo

Azioni Sagent Pharmaceuticals Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Nichi-Iko Pharmaceutical Co., Ltd. : Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stock of Sagent Pharmaceuticals, Inc.	29/08/16
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10 g due to presence of iron oxide particulate matter	17/08/16
Nichi-Iko Pharmaceutical Co., Ltd. : Announces Expiration of HSR Waiting Period for Proposed Acquisition of Sagent Pharmaceuticals, Inc.	09/08/16
Sagent Pharmaceuticals : Shepard Vision, Inc., a Wholly-Owned Subsidiary of Nichi-Iko Pharmaceutical Co., Ltd, Commences All-Cash Tender Offer of $21.75 Net Per Share to Acquire All Outstanding Shares of Sagent Pharmaceuticals, Inc.	01/08/16
Allergan : Teva, Allergan win U.S. antitrust approval for generics deal	27/07/16

Dirigenti	Titolo	Età	Da
Jeffrey W. Greve DFI	Director of Finance/CFO	49	01/02/11
Jerry Webb COO	Chief Operating Officer	-	01/01/18
Donald R. Bullock PRN	Corporate Officer/Principal	-	01/01/07

Amministratori	Titolo	Età	Da
Frank Kung BRD	Director/Board Member	75	01/05/06

Settore